General Insuranc (GICRE)

FairStock Score: 80/100 — HIGH CONVICTION

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 1/1

Key Financials

Strengths

• P/E of 6.98 and P/B of 1.14 are optically cheap relative to ROE of 15.66%.
• Zero debt and positive free cash flow of ₹1,701 Cr provide financial stability.
• Piotroski F-Score of 8/9 suggests strong fundamental health across profitability, leverage, and efficiency.
• Promoter holding of 82.40% and dividend yield of 2.61% offer ownership stability and some income support.
• Latest quarter profit of ₹1,726 Cr with 28.15% profit growth shows passing momentum.

Concerns

• 5-year revenue CAGR of just 0.42% highlights a weak long-term growth trajectory despite recent sales growth of 13.96%.
• DCF intrinsic value of ₹110.35 is far below the current price; either the model is too conservative or the market is overly optimistic.
• Altman Z-Score of 0.97 signals financial stress risk, though the metric is less reliable for insurance companies.
• General insurance earnings can be cyclical; a single good year does not confirm durable outperformance.

AI Analysis

Let me start with what I like. A P/E of 6.98, a P/B of 1.14, and an ROE of 15.66% on a book value of ₹350.55 — that is a business earning a decent return on equity while priced at barely above book. Debt/equity is zero, free cash flow is ₹1,701 Cr, and the Piotroski score of 8/9 tells me the balance sheet quality is not a fluke. A dividend yield of 2.61% gives me something while I wait. Promoter holding of 82.40% also provides ownership stability. But I have to be honest: this is not a simple growth story. The 5-year revenue CAGR of 0.42% is almost flat, and that is a red flag for anyone expecting steady compounding. The latest quarter shows sales of ₹12,589 Cr and net profit of ₹1,726 Cr, and profit growth of 28.15% is encouraging, but in general insurance a good year can reverse quickly. The Altman Z-score of 0.97 would worry me in an industrial company; for an insurer I treat it as less meaningful, but I cannot ignore it completely. The DCF value of ₹110.35 is far below the price of ₹398.45, which reminds me that insurance cash flows are hard to model, and the market is paying a large premium over that conservative estimate. The Graham Number of ₹657.92 points to a 41.78% margin of safety, but Graham would also want growth, stability, and predictable earnings. With only 0.42% revenue growth over five years, this is a cyclical value stock, not a stalwart. I would not chase momentum. I would buy only with the mindset that book value and underwriting cycles drive returns, and I would demand that the recent growth be proven for several more quarters.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer